Stay updated on GLPG1690 in IPF: ISABELA2 Clinical Trial
Sign up to get notified when there's something new on the GLPG1690 in IPF: ISABELA2 Clinical Trial page.

Latest updates to the GLPG1690 in IPF: ISABELA2 Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedThe page has undergone significant content changes, including the removal of detailed study information regarding GLPG1690 and its efficacy in treating Idiopathic Pulmonary Fibrosis, while retaining the study's name and revision number.SummaryDifference18%
- Check16 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.0%
- Check23 days agoNo Change Detected
- Check59 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference0.6%
- Check67 days agoChange DetectedThe web page now includes a notice about heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.SummaryDifference0.6%
- Check81 days agoChange DetectedThe website has been updated from version 2.14.1 to 2.14.2.SummaryDifference0.0%
- Check95 days agoChange DetectedThe website has been updated from version 2.14.0 to 2.14.1.SummaryDifference0.0%
Stay in the know with updates to GLPG1690 in IPF: ISABELA2 Clinical Trial
Enter your email address, and we'll notify you when there's something new on the GLPG1690 in IPF: ISABELA2 Clinical Trial page.